{
    "eid": "2-s2.0-85146781808",
    "title": "State of the Art and Future of Stem Cell Therapy in Ischemic Stroke: Why Don\u2019t We Focus on Their Administration?",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Bioengineering",
            "@code": "1502",
            "@abbrev": "CENG"
        }
    ],
    "keywords": [
        "mechanism of stem cells therapy",
        "precondition",
        "route of administration",
        "stem cells therapy",
        "stroke"
    ],
    "authors": [
        "Andrea Valeri",
        "Emanuela Mazzon"
    ],
    "citedby-count": 0,
    "ref-count": 82,
    "ref-list": [
        "On the Origin of the Term \u201cStem Cell",
        "Current state of stem cell-based therapies: An overview",
        "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement",
        "Management of acute ischemic stroke",
        "Pathophysiologic Cascades in Ischemic Stroke",
        "The Role of Oxidative Stress in Neurodegenerative Diseases",
        "Proliferating resident microglia after focal cerebral ischaemia in mice",
        "Cytotoxicity of microglia",
        "Intracerebral haemorrhage",
        "Molecular pathophysiology of cerebral hemorrhage: Secondary brain injury",
        "Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke",
        "The Next Step in the Treatment of Stroke",
        "Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association",
        "CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury",
        "Is Fluoxetine Good for Subacute Stroke? A Meta-Analysis Evidenced From Randomized Controlled Trials",
        "Advances in Stroke: Therapies Targeting Stroke Recovery",
        "Optimizing the success of cell transplantation therapy for stroke",
        "Application of Stem Cells in Stroke: A Multifactorial Approach",
        "Mesenchymal stem cell therapy for ischemic stroke: Novel insight into the crosstalk with immune cells",
        "Multipotent Stem Cell and Current Application",
        "Stem Cells: Classifications, Controversies, and Clinical Applications",
        "Embryo-derived stem cells: Of mice and men",
        "Core transcriptional regulatory circuitry in human embryonic stem cells",
        "Tissue-specific stem cells: Friend or foe?",
        "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement",
        "Umbilical cord stem cells: Background, processing and applications",
        "Stem Cells Applications in Regenerative Medicine and Disease Therapeutics",
        "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors",
        "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts",
        "Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders",
        "Enhancing oxidative phosphorylation over glycolysis for energy production in cultured mesenchymal stem cells",
        "Metabolic Switching of Cultured Mesenchymal Stem Cells Creates Super Mitochondria in Rescuing Ischemic Neurons",
        "Interleukin-17A promotes the differentiation of bone marrow mesenchymal stem cells into neuronal cells",
        "Hypoxic Culture Promotes Dopaminergic-Neuronal Differentiation of Nasal Olfactory Mucosa Mesenchymal Stem Cells via Upregulation of Hypoxia-Inducible Factor-1\u03b1",
        "Ischemia-Induced Multipotent Stem Cells Isolated from Stroke Patients Exhibit Higher Neurogenic Differentiation Potential than Bone Marrow-Derived Mesenchymal Stem Cells",
        "Mouse model of middle cerebral artery occlusion",
        "Involvement of T-bet and GATA3 transcription factors in Mesenchymal stem cells and royal jelly combination treatment in brain stroke",
        "Stereotaxic gene delivery in the rodent brain",
        "Stem Cell Therapy and Administration Routes After Stroke",
        "Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase I clinical trial",
        "Intracerebral implantation of human neural stem cells and motor recovery after stroke: Multicentre prospective single-arm study (PISCES-2)",
        "Transplantation of Roxadustat-preconditioned bone marrow stromal cells improves neurological function recovery through enhancing grafted cell survival in ischemic stroke rats",
        "Upregulating HIF-1\u03b1 to Boost the Survival of Neural Stem Cells via Functional Peptides-Complexed MRI-Visible Nanomedicine for Stroke Therapy",
        "Preconditioning with Trehalose Protects the Bone Marrow-Derived Mesenchymal Stem Cells Under Oxidative Stress and Enhances the Stem Cell-Based Therapy for Cerebral Ischemic Stroke",
        "Targeting 17\u03b2-estradiol biosynthesis in neural stem cells improves stroke outcome",
        "Glycosaminoglycan scaffolding and neural progenitor cell transplantation promotes regenerative immunomodulation in the mouse ischemic brain",
        "Bone marrow-derived mesenchymal stem cells overexpressed with miR-182-5p protects against brain injury in a mouse model of cerebral ischemia",
        "Dental pulp stem cell transplantation facilitates neuronal neuroprotection following cerebral ischemic stroke",
        "Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution",
        "Mesenchymal stem cell delivery routes and fate",
        "Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury",
        "Intra-Arterial Delivery of Cell Therapies for Stroke",
        "Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats",
        "Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?",
        "Ischemic-hypoxic preconditioning enhances the mitochondrial function recovery of transplanted olfactory mucosa mesenchymal stem cells via miR-181a signaling in ischemic stroke",
        "Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats",
        "Uncovering the characteristics of the gut microbiota in patients with acute ischemic stroke and phlegm-heat syndrome",
        "OM-MSCs Alleviate the Golgi Apparatus Stress Response following Cerebral Ischemia/Reperfusion Injury via the PEDF-PI3K/Akt/mTOR Signaling Pathway",
        "Intracerebroventricular, Intracerebral and Intrathecal",
        "Mesenchymal stem cell aggregation mediated by integrin \u03b14/VCAM-1 after intrathecal transplantation in MCAO rats",
        "Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model",
        "Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)",
        "Adipose-derived mesenchymal stem cells reduced transient cerebral ischemia injury by modulation of inflammatory factors and AMPK signaling",
        "Human placenta mesenchymal stem cell protection in ischemic stroke is angiotensin converting enzyme-2 and masR receptor-dependent",
        "The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion",
        "Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia",
        "Intranasal delivery of cells to the brain",
        "Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage",
        "Therapeutic potential of hair follicle-derived stem cell intranasal transplantation in a rat model of ischemic stroke",
        "Optimization of an Intranasal Route for the Delivery of Human Neural Stem Cells to Treat a Neonatal Hypoxic-Ischemic Brain Injury Rat Model",
        "Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice",
        "Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke",
        "Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice",
        "Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats",
        "Chapter 15\u2014Effects of Alcohol on the Corpus Callosum",
        "Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice",
        "Intravenous autologous bone marrow mononuclear cells for ischemic stroke",
        "Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): A first-in-human, open-label intervention study",
        "Adult Stem Cell Therapy for Stroke: Challenges and Progress"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ministry of Health"
    ]
}